Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Critical nodes in signalling pathways: insights into insulin action.

Taniguchi CM, Emanuelli B, Kahn CR.

Nat Rev Mol Cell Biol. 2006 Feb;7(2):85-96. Review.

PMID:
16493415
2.

[Signal transduction from the insulin receptor].

Asano T.

Nihon Rinsho. 2002 Jul;60 Suppl 7:240-5. Review. Japanese. No abstract available.

PMID:
12238054
3.

[Insulin signalling system and mechanism of insulin resistance].

Hino Y, Ogawa W, Kasuga M.

Nihon Rinsho. 2000 Feb;58(2):297-303. Review. Japanese.

PMID:
10707548
4.

Signalling by insulin and IGF receptors: supporting acts and new players.

Siddle K.

J Mol Endocrinol. 2011 Jun 17;47(1):R1-10. doi: 10.1530/JME-11-0022. Print 2011 Aug. Review.

PMID:
21498522
5.

Regulation of beta-cell mass and function by the Akt/protein kinase B signalling pathway.

Elghazi L, Rachdi L, Weiss AJ, Cras-Méneur C, Bernal-Mizrachi E.

Diabetes Obes Metab. 2007 Nov;9 Suppl 2:147-57. Review.

PMID:
17919189
6.

[Signal transduction of insulin receptor].

Liu R, Bai H, Liu BW.

Sheng Li Ke Xue Jin Zhan. 2001 Jul;32(3):254-6. Review. Chinese. No abstract available.

PMID:
12545802
7.

[Regulation of insulin signaling and its disorder].

Araki E, Kondo T.

Nihon Yakurigaku Zasshi. 2005 Mar;125(3):120-4. Review. Japanese. No abstract available.

PMID:
15855728
8.

Genetic control of cell size.

Stocker H, Hafen E.

Curr Opin Genet Dev. 2000 Oct;10(5):529-35. Review.

PMID:
10980431
9.

Phosphoinositide signalling pathways in metabolic regulation.

Foukas LC, Withers DJ.

Curr Top Microbiol Immunol. 2010;346:115-41. doi: 10.1007/82_2010_59. Review.

PMID:
20517721
10.

PLC and PI3K/Akt/mTOR signalling in disease and cancer.

Follo MY, Manzoli L, Poli A, McCubrey JA, Cocco L.

Adv Biol Regul. 2015 Jan;57:10-6. doi: 10.1016/j.jbior.2014.10.004. Epub 2014 Nov 26. Review.

PMID:
25482988
11.

IRS2 and PTP1B: Two opposite modulators of hepatic insulin signalling.

Valverde AM, González-Rodríguez A.

Arch Physiol Biochem. 2011 Jul;117(3):105-15. doi: 10.3109/13813455.2011.557386. Epub 2011 Mar 14. Review.

PMID:
21401320
12.

Early steps in insulin action.

Dorrestijn J, van Bussel FJ, Maassen JA, Gomes de Mesquita DS.

Arch Physiol Biochem. 1998 Oct;106(4):269-89. Review.

PMID:
10417854
13.

The role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes.

Kaidanovich O, Eldar-Finkelman H.

Expert Opin Ther Targets. 2002 Oct;6(5):555-61. Review.

PMID:
12387679
14.

[Proteins involved in longevity].

Hirose S.

Seikagaku. 2005 Nov;77(11):1417-9. Review. Japanese. No abstract available.

PMID:
16370361
15.

Clinical review 125: The insulin receptor and its cellular targets.

Kido Y, Nakae J, Accili D.

J Clin Endocrinol Metab. 2001 Mar;86(3):972-9. Review.

PMID:
11238471
16.

The PI3' kinase pathway in interferon signaling.

Kaur S, Uddin S, Platanias LC.

J Interferon Cytokine Res. 2005 Dec;25(12):780-7. Review.

PMID:
16375606
17.

[Mechanism of GH induced insulin resistance].

Kobayashi M, Takano A.

Nihon Rinsho. 2002 Jul;60 Suppl 7:265-72. Review. Japanese. No abstract available.

PMID:
12238058
18.

Muscle atrophy in chronic kidney disease results from abnormalities in insulin signaling.

Price SR, Gooch JL, Donaldson SK, Roberts-Wilson TK.

J Ren Nutr. 2010 Sep;20(5 Suppl):S24-8. doi: 10.1053/j.jrn.2010.05.007. Review.

19.

Insulin-like growth factor-I receptor signal transduction: at the interface between physiology and cell biology.

Butler AA, Yakar S, Gewolb IH, Karas M, Okubo Y, LeRoith D.

Comp Biochem Physiol B Biochem Mol Biol. 1998 Sep;121(1):19-26. Review.

PMID:
9972281
20.

Role of PI3K/AKT, cPLA2 and ERK1/2 signaling pathways in insulin regulation of vascular smooth muscle cells proliferation.

Isenović ER, Kedees MH, Tepavcević S, Milosavljević T, Korićanac G, Trpković A, Marche P.

Cardiovasc Hematol Disord Drug Targets. 2009 Sep;9(3):172-80. Review.

PMID:
19534657

Supplemental Content

Support Center